Key Takeaways for Premier Dental Sellers
- Premier dental practices ($1M+ revenue) usually sell once in a career, so broker choice can strongly affect proceeds and deal success.
- Broker fees typically range from 6%–12% of transaction value, and some tiered structures can weaken incentives to push for top price.
- CPA-led, diligence-grade valuations can reduce re-trade risk and hold up under buyer scrutiny better than free or informal estimates.
- McLerran & Associates reports high close rates with a vetted national buyer pool and genuine dual-path (private buyer vs. DSO) experience.
- Owners ready to explore options can schedule a free, confidential discovery call with McLerran & Associates to discuss practice value and exit strategy.
How Dental Practice Commissions Work for Premier Practices
Most dental practice brokers use a success-based commission model, so the seller pays the fee only when the transaction closes. A common commission range for U.S. dental practice sales is 6%–12% of the total transaction value. On a $1.5 million transaction, that range equates to $90,000–$180,000 in broker fees.
Fee structures vary across broker categories, and each structure creates different incentive dynamics for the advisor.
- Flat percentage: A single rate applied to the full sale price, often used for smaller practices, keeps the broker focused on total price but does not reward extra effort at higher tiers.
- Tiered or Lehman-style: A Double Lehman scale charges 10% on the first $1 million of deal value, 8% on the second, 6% on the third, 4% on the fourth, and 2% on everything above $4 million. This structure front-loads broker compensation into the first dollars of deal value and can reduce motivation to fight for the last dollars.
- Hybrid retainer plus reduced commission: A hybrid model combines an upfront retainer of $2,000–$10,000 with a reduced success fee of 4%–8% at closing. The retainer compensates initial work, while the success fee still ties part of compensation to the final price.
- Minimum fees: Minimum commissions of $30,000–$50,000 are common for smaller deals where a percentage alone would not cover the work required to market, negotiate, and close the transaction.
Incentive alignment can be a key factor. A tiered structure that pays most of its fee on the first million of deal value gives a broker limited financial motivation to push for the last $200,000 of value, even though those dollars matter greatly to the seller. A flat or retainer-plus-commission model can create different tradeoffs between upfront certainty for the broker and upside tied to final price. Sellers of premier practices can ask any broker to explain exactly how their fee is calculated and where their incentive to maximize price is strongest.
Find out how McLerran & Associates structures its dental-only, sell-side fees so your advisor’s incentives stay closely aligned with your outcome.
What Makes a Good Dental Practice Valuation for a Sale
Valuation can be one of the quietest sources of financial loss in a dental practice sale, and it is often where broker categories differ most. Fee structure determines what your broker earns, while valuation can determine what you ultimately take home.
Two valuation methods tend to matter most for premier practices.
- Collections multiples: This method is typically used in doctor-to-doctor (private buyer) transactions, where value is expressed as a percentage of trailing 12-month collections. General dental practices sold to private buyers are often valued in the range of 60%–85% of trailing 12-month collections.
- EBITDA multiples: EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. In plain terms, it reflects the practice’s operating profit after removing non-recurring and owner-specific expenses. DSO and private equity buyers usually apply EBITDA multiples to determine enterprise value. Dental practice valuations commonly range from 5x to 9x EBITDA.
The quality of the EBITDA analysis, especially how thoroughly add-backs are documented, can determine whether the valuation holds up when a buyer’s diligence team reviews it. Add-backs include discretionary, personal, and non-recurring expenses that, when properly supported, can increase reported profitability. Without clear documentation, the valuation becomes vulnerable to re-trading during due diligence.
A “free” or back-of-the-napkin valuation is often set by the buyer and can become the anchor that quietly determines what the seller walks away with. Dental practices that prepare carefully for sale, including building defensible financial documentation, can often command stronger pricing and achieve higher close rates than unprepared practices.
McLerran & Associates builds a CPA-led, diligence-grade EBITDA analysis before any practice goes to market. The team unpacks every add-back so the number is designed to hold when buyers look closely and so the deal is less likely to be re-traded at a lower price during due diligence.
Discuss a CPA-led valuation for your practice and see what a defensible, diligence-grade analysis could support in the current market.
Questions to Ask Dental Practice Brokers Before You Sign
Specific questions can reveal whether a broker behaves as a true sell-side advocate or mainly as a listing service. The answers can highlight gaps in valuation rigor, buyer access, and transaction execution that may affect your final proceeds.
- Is your valuation CPA-led and diligence-grade, or is it a free estimate? A free valuation is often a lead-generation tool. Ask who prepares it, what methodology is used, and whether it has held up through buyer due diligence on prior transactions.
- How many active buyers are in your pool, and how are they vetted? A broker with access to only 1 or 2 DSO relationships cannot create strong competitive tension. Ask for the approximate number of pre-qualified buyers and how poorly performing buyers are screened out.
- What is your transaction rate, and how do you define it? Industry close rates for unrepresented sellers can run as low as 15%–20%. Ask what percentage of the broker’s listed practices actually close and how that figure compares to the broader market.
- Do you represent both private buyers and DSOs, or only one path? A broker who works only one exit lane cannot provide a genuine side-by-side comparison. Ask what percentage of their closed transactions in the past 12 months were doctor-to-doctor versus DSO affiliations.
- How do you defend the valuation if a buyer tries to re-trade the deal during due diligence? Re-trading, where a buyer lowers an offer after the letter of intent is signed, is a common way sellers lose value. Ask specifically how the broker addresses this situation.
- What happens if my deal falls apart, and what is your re-engagement process? Fragile deals can occur. A broker with a deep buyer pool and structured process can re-engage quickly, while a local generalist may have exhausted their network on the first attempt.
Choosing Between a DSO Sale and a Private Buyer
The 2 main exit paths, private buyer and DSO, can differ in structure, timeline, post-close commitments, and net proceeds. Neither path is universally superior, and the better fit can depend on practice size, the owner’s goals, and the specific buyers active in the market.
Doctor-to-doctor (private buyer) transactions are usually structured as a straightforward asset purchase. Solo doctor deals are often simpler, with 75%–85% cash at close, no equity component, and 6–24 months of seller transition. Doctor-to-doctor transactions tend to close faster, with a typical close timeline of 60–120 days for solo doctor buyers, and they can allow a cleaner exit for owners who want to step away from clinical practice relatively quickly.
DSO and private equity affiliations are generally more complex and can shift more risk to the seller. A typical DSO deal structure includes 60%–80% cash at close, 15%–30% earnouts tied to performance targets over 3–5 years, and 5%–20% equity rollover that remains illiquid until a future event. An earnout is a deferred payment tied to hitting future revenue or EBITDA targets, so a portion of the sale price is not guaranteed at closing. Equity rollover means the seller keeps a stake in the DSO platform, which may grow in value at a future recapitalization but also carries investment risk. DSO deals commonly require 3–5 years of post-close work as an associate dentist with production-based compensation.
Owners in the $1.5–3 million revenue range often qualify for both paths, so a side-by-side comparison of real numbers can be especially useful. A broker who works only one path cannot provide that comparison. Because McLerran & Associates runs private-buyer and DSO transactions in roughly equal measure (approximately 50/50), the firm can prepare a side-by-side valuation so owners choose their path with more complete information.
Request a side-by-side DSO vs. private-buyer analysis for your practice before you commit to either lane.
Dental Practice Broker Comparison Table
The following table compares 5 common broker categories across factors that can affect net proceeds and transaction success for premier practices.
| Dimension | DIY / For-Sale-By-Owner | Local Generalist Broker | Multi-Vertical Advisor | Free-Valuation Firm | McLerran & Associates |
|---|---|---|---|---|---|
| Broker fee range | No broker fee, but full information disadvantage | 8%–12% success fee, paid at closing | Varies, retainer plus 4%–8% success fee common for complex deals | Free valuation (lead-generation model), commission structure varies | Paid, CPA-led valuation, success-based commission, “we sell practices, we don’t just list them” |
| Valuation method | Buyer-set, no independent analysis | Variable, often collections-multiple only | Variable, depends on vertical expertise | Free or napkin-math estimate, not diligence-grade | CPA-led EBITDA analysis, diligence-grade, designed to hold through buyer scrutiny without re-trade |
| Buyer pool | One buyer, no competitive tension | Small local network, typically 1–2 DSO relationships | Broader network, not dental-specific | Partial buyer list, not fully vetted | Large premier private-buyer pool nationally, vetted DSO/PE buyers, poorly performing DSOs blacklisted, structured auction often generating approximately 10 offers |
| Close rate | ~15%–20% for unrepresented sellers | Below market average, infrequent transactions can reduce buyer confidence | Variable, not dental-specific | ~35%–40% industry norm | ~85%–90% transaction rate across approximately 2,000 completed sales and ~$2 billion in closed volume |
| Private buyer vs. DSO balance | Whichever buyer the owner finds independently | Usually one path only | Sometimes both, not dental-specific depth | Usually one path only | ~50/50 split between private-buyer and DSO transactions, genuine side-by-side comparison available |
Conclusion and Next Step for Premier Practice Owners
For owners of premier dental practices, the broker category chosen at the outset of a transition can be some of the most significant determinants of final outcome. This influence can extend beyond price to deal structure, post-close quality of life, and whether the transaction closes at all. The data in this comparison suggests that dental-only representation, CPA-led diligence, a vetted and competitive buyer pool, and genuine dual-path expertise can support stronger outcomes than generalist or single-lane alternatives.
McLerran & Associates has guided owners through approximately 2,000 successful practice sales, evaluated more than 10,000 practices, and closed roughly $2 billion in transaction volume over approximately 35 years. The firm works both paths with the balance described earlier, builds every engagement on a CPA-led EBITDA analysis that is designed to hold through diligence, and creates competition among a vetted national buyer pool so owners negotiate from a position of strength rather than from a single offer.
The biggest financial decision of a dental career can benefit from a sell-side advisor and advocate whose practice focuses on one outcome: improving yours.
Connect with McLerran & Associates for a free, confidential discovery call — call (512) 900-7989, email info@dentaltransitions.com, or visit the contact page. Whether a transition is imminent or several years away, an early conversation can clarify your options.
Frequently Asked Questions
What is the difference between a dental practice broker and a sell-side advisor?
A dental practice broker typically lists a practice for sale and facilitates introductions between a seller and a buyer, similar to a real estate agent. A sell-side advisor and advocate usually does more, including building a diligence-grade valuation, running a structured competitive bid process among a vetted buyer pool, negotiating the letter of intent and deal structure on the seller’s behalf, defending the valuation through due diligence, and managing the transaction through to close. For owners of premier practices generating $1 million or more in annual revenue, this distinction can matter because the complexity of the transaction, especially in DSO affiliations involving cash, equity, and earnout components, often requires more than a listing service. McLerran & Associates positions itself as a sell-side advisor and advocate, not a listing broker, and its transaction rate reflects the impact a full-process engagement can have.
How do I know whether to sell to a private buyer or a DSO?
The right path can depend on several factors, including the size and profitability of the practice, the owner’s goals for post-close involvement, the owner’s comfort with retaining equity in a DSO platform, and the specific buyers active in the market at the time of sale. As a general framework, smaller premier practices, roughly in the $1–$1.5 million revenue range, often fit a doctor-to-doctor sale where another dentist purchases the practice outright. Larger practices, particularly those above $1.5 million in revenue, may attract meaningful DSO interest and can benefit from a competitive bid process among multiple corporate buyers. Owners in the middle, roughly $1.5–$3 million in revenue, can often pursue either path, and a side-by-side valuation that quantifies what the practice is worth in both markets can be helpful. Because McLerran & Associates works both paths in roughly equal measure, it can produce that comparison rather than steering an owner toward the path the broker knows best.
Why does a “free” dental practice valuation carry risk?
A free valuation is typically a lead-generation tool rather than a diligence-grade financial analysis. It may rely on a simple revenue multiple or a quick EBITDA estimate without fully unpacking add-backs, which are discretionary, personal, and non-recurring expenses that, when properly documented, increase the practice’s true profitability. The risk can be twofold. First, an inflated free valuation that cannot be defended in due diligence can lead to re-trading, where the buyer lowers the offer after the letter of intent is signed once their diligence team identifies weaknesses in the financial analysis. Second, an undervalued free estimate can anchor the negotiation at a lower number, leaving real proceeds on the table before the conversation even begins. A CPA-led, diligence-grade valuation completed before the practice goes to market can help control the narrative around profitability and give the seller a defensible number when buyers scrutinize it.
What is a re-trade, and how can it be prevented?
A re-trade occurs when a buyer, typically after signing a letter of intent (LOI) and beginning due diligence, attempts to reduce the agreed purchase price based on issues discovered during their financial review. Common triggers include unsupported add-backs in the EBITDA analysis, weak accounts receivable, high owner dependence on production, or documentation gaps in financial records. Re-trades are one of the more common ways sellers of premier practices lose value, and they tend to be more frequent when the initial valuation was not built to withstand scrutiny. Prevention usually starts with diligence-grade financial preparation before the practice goes to market, including organizing 3 or more years of tax returns and profit-and-loss statements, documenting every add-back, verifying active patient counts, and separating personal and business expenses. A sell-side advisor who has done this work up front can also defend the valuation during diligence by reminding buyers that other vetted bidders remain available, which can help preserve competitive tension through the close.
How long does a dental practice sale typically take?
The full process, from the decision to sell through closing, can range from roughly 6 months to more than a year, depending on practice type, buyer category, and how well-prepared the seller is at the outset. Doctor-to-doctor transactions tend to close faster, with a typical close timeline of 60–120 days for solo doctor buyers. DSO deals commonly involve 3–6 months of active process from LOI to close, while the full dental practice sale timeline from engagement to close often spans 6–12 months. Preparation before going to market, including organizing financial records, securing the lease, and completing a diligence-grade valuation, can shorten the active transaction phase and may reduce the risk of delays that erode buyer confidence or deal momentum.
